Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

133.3K
Overview
133.3K
The Extracellular Matrix01:42

The Extracellular Matrix

89.6K
Overview
89.6K
Humoral Immune Responses01:36

Humoral Immune Responses

84.2K
Overview
84.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How <i>Mycobacterium tuberculosis</i> Subverts Innate and Adaptive Immunity and Their Crosstalk: Implications for Vaccine Design.

Vaccines·2026
Same author

Lysosomal cholesterol overload impairs the innate-adaptive immune axis in tuberculosis granulomas.

Nature microbiology·2026
Same author

Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness.

American journal of respiratory cell and molecular biology·2025
Same author

Macrophage-T cell interactions promote SLAMF1 expression for enhanced TB defense.

Nature communications·2025
Same author

Period-doubling in the phase dynamics of a shunted HgTe quantum well Josephson junction.

Nature communications·2025
Same author

The <i>Mycobacterium tuberculosis</i> lipid, PDIM, inhibits the NADPH oxidase and autophagy.

Autophagy·2024
Same journal

Correction.

Autophagy·2026
Same journal

Targeting lysosomes with a novel chloroquine derivative induces irreversible lysosomal damage and disrupts autophagosome and lysosome assembly in cancer.

Autophagy·2026
Same journal

Targeting the SNAI1-LAMP3 axis to restore lysosomal function and alleviate autophagic flux impairment to delay retinal degeneration.

Autophagy·2026
Same journal

Hypoxia-preconditioned dental pulp stem cells alleviate acetaminophen-induced liver failure via promoting MYC-HIF1A/HIF-1α-BNIP3-mediated mitophagy.

Autophagy·2026
Same journal

<i>Mir452</i> protects against septic acute kidney injury by targeting <i>Apaf1</i> to relieve CASP9-mediated suppression of autophagy.

Autophagy·2026
Same journal

CAMKV is an ISG and facilitates the degradation of rabies virus phosphoprotein via SQSTM1-mediated selective autophagy.

Autophagy·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.3K

Why macrophages cannot LAP up TB.

Stefan Köster1, Sandeep Upadhyay2, Jennifer A Philips2

  • 1a Division of Infectious Diseases, Department of Medicine , New York University School of Medicine , New York , NY , USA.

Autophagy
|January 10, 2018
PubMed
Summary
This summary is machine-generated.

Mycobacterium tuberculosis evades immune cells by blocking a key degradation pathway. A virulence factor, CpsA, prevents LC3-associated phagocytosis (LAP), but its absence allows macrophages to clear the bacteria.

Keywords:
LC3-associated phagocytosisLytR-CpsA-PsrMycobacterium tuberculosisNADPH oxidaseinnate immunity

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.8K
Generating Lap Joints Via Friction Stir Spot Welding on DP780 Steel
07:18

Generating Lap Joints Via Friction Stir Spot Welding on DP780 Steel

Published on: August 13, 2019

7.4K

Related Experiment Videos

Last Updated: Feb 15, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

8.3K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.8K
Generating Lap Joints Via Friction Stir Spot Welding on DP780 Steel
07:18

Generating Lap Joints Via Friction Stir Spot Welding on DP780 Steel

Published on: August 13, 2019

7.4K

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Mycobacterium tuberculosis (M. tuberculosis) poses a significant global health challenge, primarily by evading macrophage antimicrobial defenses.
  • M. tuberculosis inhibits phagosomal trafficking, preventing lysosomal degradation, but the precise mechanisms remain elusive.
  • LC3-associated phagocytosis (LAP) is a crucial microbicidal pathway involving LC3 association with phagosomes, initiated by macrophage pathogen recognition receptors (PRRs) and requiring NADPH oxidase and RUBCN/RUBICON.

Purpose of the Study:

  • To elucidate the mechanism by which M. tuberculosis subverts macrophage antimicrobial functions.
  • To identify specific M. tuberculosis virulence factors involved in immune evasion.
  • To investigate the role of CpsA in the context of the LC3-associated phagocytosis (LAP) pathway.

Main Methods:

  • Investigated the interaction of M. tuberculosis virulence factor CpsA with the host cell machinery.
  • Utilized macrophage and mouse models to assess the impact of CpsA on bacterial clearance.
  • Examined the recruitment of CYBB/NOX2 to mycobacterial phagosomes in the presence and absence of CpsA.
  • Analyzed the function of CpsA in relation to the LytR-CpsA-Psr protein family and cell wall assembly.

Main Results:

  • Discovered that the M. tuberculosis virulence factor CpsA directly inhibits LAP by preventing the recruitment of CYBB/NOX2 (cytochrome b-245, beta polypeptide) to the phagosome.
  • Demonstrated that M. tuberculosis mutants lacking CpsA are effectively cleared in macrophages and mice via NADPH oxidase and LAP.
  • Showed that CpsA inhibits CYBB oxidase activity independently of any known cell wall-related function.

Conclusions:

  • CpsA is a critical M. tuberculosis virulence factor that actively blocks the host's LC3-associated phagocytosis (LAP) pathway, a key innate immune mechanism.
  • Targeting CpsA or restoring LAP could represent novel therapeutic strategies against M. tuberculosis infections.
  • CpsA represents a potential evolutionary adaptation from a cell wall protein to a specialized virulence factor essential for M. tuberculosis immune evasion.